BEIJING, April 10 (Xinhua) — A new COVID-19 vaccine developed by China’s Sinopharm has recently been approved for clinical trials. The new recombinant COVID-19 vaccine, developed by the National …
Tagged By shenzhen
50 Years Later, The Legacy Of U.S.-China ‘Pingpong Diplomacy’ Faces Challenges
Judy Hoarfrost remembers the day she walked into China a half-century ago. She was 15 and the youngest member of the U.S. pingpong team, which had been in Nagoya, Japan, competing in the World …
China fines Alibaba $2.8 billion for behaving like a monopoly
China has ordered Alibaba to pay a record fine of 18.2 billion yuan ($2.8 billion) after antitrust regulators concluded that the online shopping giant had been behaving like a monopoly. Chinese state …
China tries to wear down its neighbors with pressure tactics
WASHINGTON — China is trying to wear down its neighbors with relentless pressure tactics designed to push its territorial claims, employing military aircraft, militia boats and sand dredgers to …
China’s COVID-19 vaccine output to hit 3 billion by year-end – official
CHENGDU, China (Reuters) – China’s will likely have produced 3 billion doses of COVID-19 vaccines by the end of the year, a National Health Commission official said on Saturday. Zheng Zhongwei, who …
China’s COVID-19 vaccine output could exceed 3 billion by year-end – official
China’s output of COVID-19 vaccines could reach more than 3 billion doses by the end of 2021, a National Health Commission official said on Saturday. Zheng Zhongwei, who also heads a team coordinating …
Events Leading up to China’s $2.75 Billion Fine on Alibaba
Events Leading up to China’s $2.75 Billion Fine on Alibaba The Alibaba business empire has come under intense scrutiny in China since its billionaire founder Jack Ma’s stinging public criticism of the …
China’s Sinopharm, Sinovac COVID-19 vaccines in final stages of evaluation: WHO
China’s Sinopharm, Sinovac COVID-19 vaccines are in the final stages of evaluation, said the World Health Organization (WHO). The two Chinese vaccines, once approved, will be used under the WHO’s …
Sinopharm’s protein-based COVID-19 vaccine candidate gets China clinical trial nod
BEIJING, April 10 (Reuters) – The China National Biotec Group Company (CNBG) has obtained regulatory approval to move a third COVID-19 vaccine candidate into the human testing stage in China, CNBG …
Alibaba fined $2.8 billion on competition charge in China
Party leaders worry about the dominance of China’s biggest internet companies, which are expanding into finance, health services and other sensitive areas. The party says anti-monopoly enforcement, …
China fines Alibaba billions for alleged market abuses
Platform co-founded by Jack Ma, who has criticised Chinese authorities, misused its dominance, say state regulators …
China’s Alibaba hit with record $2.75 billion antitrust fine
Chinese regulators said on Saturday they have fined Alibaba Group Holding Ltd a domestic record $2.75 billion for antitrust violations, amid an unprecedented regulatory crackdown on Jack Ma’s company …
China able to produce 5b COVID-19 vaccine doses annually by 2022
China is expected to achieve an annual production capacity of 5 billion doses of COVID-19 vaccine by the end of next year, with nearly 70 percent of its population vaccinated, said Feng Duojia, …
